Verlukast is a potent, selective oral antagonist of the leukotriene D4 receptor utilized in the management of asthma by inhibiting bronchoconstriction and airway inflammation. This category contains high-quality… Read more
Verlukast is a potent, selective oral antagonist of the leukotriene D4 receptor utilized in the management of asthma by inhibiting bronchoconstriction and airway inflammation. This category contains high-quality reference standards for Verlukast, alongside a comprehensive range of related compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled versions. These analytical standards are essential for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control throughout the drug development lifecycle. By utilizing these characterized reference materials, researchers can accurately identify, quantify, and monitor degradation products and metabolic pathways. The inclusion of stable isotope-labelled compounds further supports precise quantification in complex biological matrices, ensuring reliable data during stability studies and release testing of drug products.